Using secondary data sources for pharmacoepidemiology and outcomes research.
about
The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines'Big data' in mental health research: current status and emerging possibilitiesCorrelation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reportingThe Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchersA validated case definition for chronic rhinosinusitis in administrative data: a Canadian perspective.Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies.Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators.Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data.An introduction to the fundamentals of cohort and case-control studiesOvert hepatic encephalopathy in Italy: clinical outcomes and healthcare costs.Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification.Real-world impact of reminder packaging on antihypertensive treatment adherence and persistence.The RECORD reporting guidelines: meeting the methodological and ethical demands of transparency in research using routinely-collected health dataChanging prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation.Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer.Use of pharmacy records to measure treatment adherence: a critical review of the literature.The intriguing future of pharmacoepidemiology.Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.Invited Commentary on Stewart and Davis " 'Big data' in mental health research-current status and emerging possibilities".Principles of drug literature evaluation for observational study designs.Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?Linkage of national soil quality measurements to primary care medical records in England and Wales: a new resource for investigating environmental impacts on human healthThe Challenges and Opportunities of Pharmacoepidemiology in Bone DiseasesComplex questions command complex analyses: comparative effectiveness of drug treatment strategies in atrial fibrillationChronic Kidney Disease: Evolution of Healthcare Costs and Resource Consumption from Predialysis to Dialysis in Piedmont Region, Italy
P2860
Q21131774-3645E6FF-8E5A-497A-93C7-5863A892087EQ26741297-69613DF5-51C5-4EB9-8827-412B18AAD4D5Q28477448-16BE5430-36A3-415B-934A-936CC3D313F6Q31015134-4C83C1ED-A45B-4196-998D-CCD183FA025BQ31102408-C9A16DBD-76DE-47C7-BEF6-0BD7D2FE90CEQ31111099-02183382-F0E2-48FE-9C5C-A6768DCD1B1FQ33812197-7434FE4D-9385-42FE-B7AD-A2D3F06517BEQ33829782-148FCB1D-EB35-4295-8625-7AA0EFB0B7D3Q34427860-09BC2E6B-5839-4178-A08D-2B06AFFC54E5Q35862181-22007A71-D2D9-4BD6-AA61-55D62312D487Q36064517-2E4E7145-2A26-42AE-AA98-4654DC74E1D1Q36173141-4F22FE36-FB69-455A-83DA-2A127224BE3CQ36178861-1C7317D6-B1B1-4618-84F0-235113C89598Q36954288-4901D686-6BB3-4BFA-BF52-2F25BC6A9F77Q38364806-32A79D9B-7A07-414A-806B-34AC2C950DDDQ38819475-5D81D206-5D57-4686-9AF5-314E6052A67FQ39422831-B9A97B61-639B-4D21-8907-E4D2943BE6C6Q39778042-8AE6B44A-3264-473E-BAA6-7B2DB64C803BQ44970808-9C2E8757-A9E9-4E65-8F0D-CAD85FAE2D02Q45236376-76859A33-CF03-40A1-9E93-3071052CF076Q48156007-6CDF3D01-01C4-4C58-8F98-52FE70C22D16Q57093358-41B94AE1-4662-4289-854A-C7615241215BQ57145898-0696C894-9245-4CDB-90E7-A596C158AED8Q58665533-3FB2D102-373C-432C-951F-038C28BD5641Q59050762-84C4B4CF-5484-4C9C-AEE8-0922F84613E0
P2860
Using secondary data sources for pharmacoepidemiology and outcomes research.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Using secondary data sources for pharmacoepidemiology and outcomes research.
@ast
Using secondary data sources for pharmacoepidemiology and outcomes research.
@en
type
label
Using secondary data sources for pharmacoepidemiology and outcomes research.
@ast
Using secondary data sources for pharmacoepidemiology and outcomes research.
@en
prefLabel
Using secondary data sources for pharmacoepidemiology and outcomes research.
@ast
Using secondary data sources for pharmacoepidemiology and outcomes research.
@en
P2860
P356
P1433
P1476
Using secondary data sources for pharmacoepidemiology and outcomes research.
@en
P2860
P304
P356
10.1592/PHCO.29.2.138
P407
P577
2009-02-01T00:00:00Z